FI814003L - Foerfarande foer framstaellning av terapeutiskt anvaendbara inolderivat - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara inolderivat

Info

Publication number
FI814003L
FI814003L FI814003A FI814003A FI814003L FI 814003 L FI814003 L FI 814003L FI 814003 A FI814003 A FI 814003A FI 814003 A FI814003 A FI 814003A FI 814003 L FI814003 L FI 814003L
Authority
FI
Finland
Prior art keywords
adjustment
therapeutic measures
therapeutic
measures
Prior art date
Application number
FI814003A
Other languages
English (en)
Finnish (fi)
Inventor
Peter Edward Cross
Roger Peter Dickinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI814003L publication Critical patent/FI814003L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
FI814003A 1980-12-15 1981-12-14 Foerfarande foer framstaellning av terapeutiskt anvaendbara inolderivat FI814003L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8040081 1980-12-15

Publications (1)

Publication Number Publication Date
FI814003L true FI814003L (fi) 1982-06-16

Family

ID=10517993

Family Applications (1)

Application Number Title Priority Date Filing Date
FI814003A FI814003L (fi) 1980-12-15 1981-12-14 Foerfarande foer framstaellning av terapeutiskt anvaendbara inolderivat

Country Status (22)

Country Link
US (1) US4363912A (ja)
EP (1) EP0054417B1 (ja)
JP (1) JPS57181082A (ja)
KR (1) KR830007552A (ja)
AR (1) AR229110A1 (ja)
AU (1) AU525296B2 (ja)
CA (1) CA1143737A (ja)
CS (1) CS228527B2 (ja)
DD (1) DD202290A5 (ja)
DE (1) DE3167879D1 (ja)
DK (1) DK552581A (ja)
ES (1) ES8308872A1 (ja)
FI (1) FI814003L (ja)
GR (1) GR76355B (ja)
IE (1) IE51949B1 (ja)
IL (1) IL64534A0 (ja)
NO (1) NO814264L (ja)
PH (1) PH17576A (ja)
PL (1) PL133634B1 (ja)
PT (1) PT74123B (ja)
YU (1) YU293481A (ja)
ZA (1) ZA818665B (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS229934B2 (en) * 1981-07-07 1984-07-16 Pfizer Production method subst.indolylacryte acid derivative
US4460777A (en) * 1981-11-19 1984-07-17 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4478842A (en) * 1981-11-19 1984-10-23 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
US4536505A (en) * 1983-05-17 1985-08-20 Ciba-Geigy Corporation Certain N-(pyridyl) indoles
GB8524157D0 (en) * 1984-10-19 1985-11-06 Ici America Inc Heterocyclic amides
US4609733A (en) * 1984-12-27 1986-09-02 Ciba-Geigy Corporation 3-keto-substituted-N-pyridylindoles
GB8609175D0 (en) * 1986-04-15 1986-05-21 Ici America Inc Heterocyclic carboxamides
OA11622A (en) * 1998-03-31 2004-09-16 Inst For Pharm Discovery Inc Substituted indolealkanoic acids.
TNSN99224A1 (fr) 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
WO2001051489A2 (en) * 2000-01-14 2001-07-19 The Institutes For Pharmaceutical Discovery, Llc Methods for lowering uric acid levels
BR0316583A (pt) * 2002-12-10 2005-10-04 Wyeth Corp Derivados de ácido acético 3-alquil e 3-arilalquil 1h-indol-1-il substituìdo como inibidores do inibidor-1 do ativador do plasminogênio (pai-1)
GB0324763D0 (en) 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
RU2458918C2 (ru) 2006-07-22 2012-08-20 Оксаген Лимитед Соединения, обладающие антагонистической активностью по отношению к crth2
CA2700539A1 (en) * 2007-09-24 2009-04-02 Allergan, Inc. Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity
RU2503672C2 (ru) 2008-01-18 2014-01-10 Оксаген Лимитед Соединения, обладающие активностью антагонистов crth2
US7750027B2 (en) * 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
WO2009093029A1 (en) * 2008-01-22 2009-07-30 Oxagen Limited Compounds having crth2 antagonist activity
EP2265581A1 (en) 2008-01-22 2010-12-29 Oxagen Limited Compounds having crth2 antagonist activity
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407807D0 (en) * 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407820D0 (en) * 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5173M (ja) * 1966-02-11 1967-06-19
FR7337M (ja) * 1968-01-11 1969-10-13
GB2045244B (en) 1979-03-07 1983-01-26 Pfizer Ltd 3-1-(imidazolylalkyl) indoles
US4322533A (en) * 1980-03-17 1982-03-30 Lesher George Y 1H-Indole-2,3-dione derivatives

Also Published As

Publication number Publication date
IE812928L (en) 1982-06-15
PL133634B1 (en) 1985-06-29
AR229110A1 (es) 1983-06-15
ES507960A0 (es) 1983-10-01
KR830007552A (ko) 1983-10-21
IL64534A0 (en) 1982-03-31
DE3167879D1 (en) 1985-01-31
YU293481A (en) 1984-10-31
NO814264L (no) 1982-06-16
PH17576A (en) 1984-10-01
DD202290A5 (de) 1983-09-07
GR76355B (ja) 1984-08-06
EP0054417A1 (en) 1982-06-23
EP0054417B1 (en) 1984-12-19
CA1143737A (en) 1983-03-29
AU7848881A (en) 1982-06-24
PT74123B (en) 1983-12-19
ZA818665B (en) 1982-10-27
IE51949B1 (en) 1987-04-29
ES8308872A1 (es) 1983-10-01
US4363912A (en) 1982-12-14
PT74123A (en) 1982-01-01
CS228527B2 (en) 1984-05-14
AU525296B2 (en) 1982-10-28
JPS57181082A (en) 1982-11-08
DK552581A (da) 1982-06-16
PL234253A1 (en) 1983-05-23

Similar Documents

Publication Publication Date Title
FI814003L (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara inolderivat
NO811731L (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater
NO813678L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
DOP1981004105A (es) Nuevos derivados de n-arilbenzamida
FI834498A0 (fi) Foerfarande foer diffusionssvetsning
NO814136L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-arylalkyl-3-fenyl-3-notropanol-derivater
NO814065L (no) Fremgansmaate for fremstilling av imidazolylfenylamidiner
FI813214L (fi) Terapeutiska imidazolylpyridiner
DOP1981003010A (es) Nuevos derivados de isoxazolilimidazolidinona
FI813527L (fi) Foerbaettrade makrolidantibiotika
NO149811C (no) Fremgangsmaate for rensning av p-aminofenol
NO813477L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
NO813821L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater
NO151196C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme fluorerte alkenylendiaminderivater
FI832790A (fi) Regleringsanordning foer oeppningen i en ljusbaoge foer glassmaeltningsugn
NO813263L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater
FI804061L (fi) Saett och utrustning foer behandling av hackat skoerdegods
ES503774A0 (es) Procedimiento de preparacion de n-ciclohexilbenzotiazol-2- sulfenamida
NO154193C (no) Fremgangsmaate for fremstilling av monohydratisert picotamid
NO812842L (no) Fremgangsmaate for fremstilling av aminoacetonitil-derivater
NO151154C (no) Analogi-fremgangsmaate for fremstilling av terapeutisk aktive benzyliden-derivater
SE8102469L (sv) Framstellning av nikotinamid
NO813404L (no) Fremgangsmaate for kontinuerlig fremstilling av dialkylperoksydikarbonater
NO813063L (no) Fremgangsmaate for fremstilling av 4-karbamoyloksyoksaza-fosforiner
FI813798L (fi) Foerfarande foer avlaegsnande av en belaeggning av antrakinon

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: PFIZER CORPORATION